Goeijenbier M, Van Wissen M, van de Weg C, Jong E, Gerdes VE, Mei

Goeijenbier M, Van Wissen M, van de Weg C, Jong E, Gerdes VE, Meijers JC, Brandjes DP, van Gorp EC: Review: Viral infections and mechanisms of thrombosis and bleeding. J Med Virol 2012, 84:1680–1696.PubMedCrossRef 9. Berri F, Le VB, Jandrot-Perrus M, Lina B, Riteau B: Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits. Cell Mol Life Sci 2014, 71:885–898.PubMedCrossRef 10. Bazaz R, Marriott HM, Francis SE, Dockrell DH: Mechanistic links between acute respiratory tract infections and acute coronary syndromes.

J Infect 2013, 66:1–17.PubMedCrossRef 11. Antoniak S, Mackman N: Multiple roles of the coagulation protease cascade during virus infection. Blood 2014, 123:2605–2613.PubMedCrossRef 12. Perez-Padilla R, De La R-Z, Ponce De Leon S, Hernandez M, Quinones-Falconi Lazertinib F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, Higuera A, Mondragon E, Cordova-Villalobos JA, INER Osimertinib Working Group on Influenza: Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680–689.PubMedCrossRef 13. Ohrui T, Takahashi H, Ebihara S, Matsui T, Nakayama K, Sasaki H: Influenza A virus infection and pulmonary microthromboembolism. Tohoku J Exp Med 2000, 192:81–86.PubMedCrossRef 14. Wang ZF, Su F, Lin XJ, Dai B, Kong LF, Zhao HW, Kang J: Serum D-dimer changes and prognostic implication in 2009 novel influenza A(H1N1). Thromb

Res 2011, 127:198–201.PubMedCrossRef 15. Keller TT, van der Sluijs KF, De Kruif M, Gerdes VE, Meijers JC, Florquin S, van der Poll T, van Gorp EC, Brandjes

DP, Büller HR, Levi M: Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated GS-9973 mw protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res 2006, 99:1261–1269.PubMedCrossRef 16. (-)-p-Bromotetramisole Oxalate Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B: PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 2013, 123:206–214.PubMedCentralPubMedCrossRef 17. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, Barman S, Webster RG, Webby RJ: Adaptation of pandemic H1N1 influenza viruses in mice. J Virol 2010, 84:8607–8616.PubMedCentralPubMedCrossRef 18. van den Brand JM, Stittelaar KJ, Leijten LM, Van Amerongen G, Simon JH, Osterhaus AD, Kuiken T: Modification of the ferret model for pneumonia from seasonal human influenza A virus infection. Vet Pathol 2012, 49:562–568.PubMedCrossRef 19. Stark GV, Long JP, Ortiz DI, Gainey M, Carper BA, Feng J, Bigger JE, Vela EM: Clinical profiles associated with influenza disease in the ferret model. PLoS One 2013, 8:e58337.PubMedCentralPubMedCrossRef 20. Lichenstein R, Magder LS, King RE, King JC Jr: The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a 7-year period.

Comments are closed.